Japan Equities
For the last eight years, GMO’s Asset Allocation team has held a differentiated view on Japanese equities. Long before Japan re‑e
Written byRick Friedman, John ThorndikeSource: Commentaries - Advisor Perspectives
For the last eight years, GMO’s Asset Allocation team has held a differentiated view on Japanese equities. Long before Japan re‑e